Cytomos appoints new Commercial and Innovation Officer and Techno-Commercial Adviser: Driving the commercialisation strategy as the company evolves f

23 January 2024: TechBio company, Cytomos (www.cytomotos.com) is pleased to announce the appointment of Dr Fernanda Masri as Chief Commercial and Innovation Officer and Dr Christel Fenge as Techno-Commercial Adviser. In her new role, Fernanda will spearhead Cytomos’ commercialisation strategy, as the company r...

Related Keywords

Canada ,Recipharm Biologics ,David Rigterink ,Fernanda Masri ,Christel Fenge ,Centre For Commercialization Of Regenerative Medicine ,Product Development ,Technology Expert For Regenerative Medicine ,Contract Development ,Astrazeneca ,Chief Commercial ,Innovation Officer ,Advanced Therapy Medicinal Products ,Manufacturing Organisations ,Innovation Manufacturing ,Gene Therapy ,Technology Expert ,Regenerative Medicine ,Vice President ,Product Management Fermentation Technologies ,General Manager ,